Engagement of tumor necrosis factor (TNF) receptor 1 leads to ATF-2-and p38 mitogen-activated protein kinase-dependent TNF-α gene expression

被引:85
作者
Brinkman, BMN
Telliez, JB
Schievella, AR
Lin, LL
Goldfeld, AE [1 ]
机构
[1] Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[3] Genet Inst, Small Molecule Drug Discovery Grp, Cambridge, MA 02139 USA
关键词
D O I
10.1074/jbc.274.43.30882
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Engagement of the tumor necrosis factor-alpha (TNF-alpha) receptors by the TNF-alpha ligand results in the rapid induction of TNF-alpha gene expression. The study presented here shows that autoregulation of TNF-alpha gene transcription by selective signaling through tumor necrosis factor receptor 1 (TNFR1) requires p38 mitogen-activated protein (MAP) kinase activity and the binding of the transcription factors ATF-2 and Jun to the TNF-alpha cAMP-response element (CRE) promoter element. Consistent with these findings, TNFR1 engagement results in increased p38 MAP kinase activity and p38-dependent phosphorylation of ATF-2. Furthermore, overexpression of MADD ((M) under bar AP kinase-(a) under bar ctivating (d) under bar eath (d) under bar omain protein), an adapter protein that binds to the death domain of TNFR1 and activates MAP kinase cascades, results in CRE-dependent induction of TNF-alpha gene expression. Thus, the TNF-alpha CRE site is the target of TNFR1 stimulation and mediates the autoregulation of TNF-alpha gene transcription.
引用
收藏
页码:30882 / 30886
页数:5
相关论文
共 33 条
  • [1] Aggarwal B.B., 1995, HUMAN CYTOKINES THEI
  • [2] Tumor necrosis factor receptor-associated factors (TRAFs) - a family of adaptor proteins that regulates life and death
    Arch, RH
    Gedrich, RW
    Thompson, CB
    [J]. GENES & DEVELOPMENT, 1998, 12 (18) : 2821 - 2830
  • [3] The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumour necrosis factor
    Beyaert, R
    Cuenda, A
    VandenBerghe, W
    Plaisance, S
    Lee, JC
    Haegeman, G
    Cohen, P
    Fiers, W
    [J]. EMBO JOURNAL, 1996, 15 (08) : 1914 - 1923
  • [4] 1-substituted 4-aryl-5-pyridinylimidazoles: A new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency
    Boehm, JC
    Smietana, JM
    Sorenson, ME
    Garigipati, RS
    Gallagher, TF
    Sheldrake, PL
    Bradbeer, J
    Badger, AM
    Laydon, JT
    Lee, JC
    Hillegass, LM
    Griswold, DE
    Breton, JJ
    ChabotFletcher, MC
    Adams, JL
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (20) : 3929 - 3937
  • [5] ENGELMANN H, 1990, J BIOL CHEM, V265, P14497
  • [6] CHARACTERIZATION OF BINDING AND BIOLOGICAL EFFECTS OF MONOCLONAL-ANTIBODIES AGAINST A HUMAN TUMOR NECROSIS FACTOR RECEPTOR
    ESPEVIK, T
    BROCKHAUS, M
    LOETSCHER, H
    NONSTAD, U
    SHALABY, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (02) : 415 - 426
  • [7] TUMOR-NECROSIS-FACTOR-ALPHA IS REQUIRED IN THE PROTECTIVE IMMUNE-RESPONSE AGAINST MYCOBACTERIUM-TUBERCULOSIS IN MICE
    FLYNN, JL
    GOLDSTEIN, MM
    CHAN, J
    TRIEBOLD, KJ
    PFEFFER, K
    LOWENSTEIN, CJ
    SCHREIBER, R
    MAK, TW
    BLOOM, BR
    [J]. IMMUNITY, 1995, 2 (06) : 561 - 572
  • [8] HUMAN TUMOR-NECROSIS-FACTOR-ALPHA GENE-REGULATION BY VIRUS AND LIPOPOLYSACCHARIDE
    GOLDFELD, AE
    DOYLE, C
    MANIATIS, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (24) : 9769 - 9773
  • [9] HENSEL G, 1987, LYMPHOKINE RES, V6, P119
  • [10] Different mitogen-activated protein kinase signaling pathways cooperate to regulate tumor necrosis factor a gene expression in T lymphocytes
    Hoffmeyer, A
    Grosse-Wilde, A
    Flory, E
    Neufeld, B
    Kunz, M
    Rapp, UR
    Ludwig, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (07) : 4319 - 4327